These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33999369)

  • 1. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.
    Jin YY; Lin H; Cao L; Wu WC; Ji Y; Du L; Jiang Y; Xie Y; Tong K; Xing F; Zheng F; Shi M; Pan JA; Peng X; Guo D
    Virol Sin; 2021 Oct; 36(5):913-923. PubMed ID: 33999369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
    Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
    J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
    Nguyen HT; Falzarano D; Gerdts V; Liu Q
    J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
    Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
    Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
    Zhang Y; Song W; Chen S; Yuan Z; Yi Z
    Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
    Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
    Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
    Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
    Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of two SARS-CoV-2 minigenome replicon systems.
    Zhang H; Fischer DK; Shuda M; Moore PS; Gao SJ; Ambrose Z; Guo H
    J Med Virol; 2022 Jun; 94(6):2438-2452. PubMed ID: 35137972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 replicon for high-throughput antiviral screening.
    Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.
    Wang B; Zhang C; Lei X; Ren L; Zhao Z; Wang J; Huang H
    Virol Sin; 2021 Oct; 36(5):890-900. PubMed ID: 33835389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
    Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
    Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
    Kotaki T; Xie X; Shi PY; Kameoka M
    Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.
    Wang L; Guzman M; Muñoz-Santos D; Honrubia JM; Ripoll-Gomez J; Delgado R; Sola I; Enjuanes L; Zuñiga S
    Front Cell Infect Microbiol; 2023; 13():1268227. PubMed ID: 37942479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    Liu S; Chou CK; Wu WW; Luan B; Wang TT
    J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cell culture system modeling the SARS-CoV-2 life cycle.
    Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q
    PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse genetic systems of SARS-CoV-2 for antiviral research.
    Kurhade C; Xie X; Shi PY
    Antiviral Res; 2023 Feb; 210():105486. PubMed ID: 36657881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.